SANGAMO THERAPEUTICS, INC. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f92ed8db-e183-49b4-9af2-13e16021d544/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-122.9M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-022029 |
| FY 2024 | $-97.9M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-013088 |
| FY 2023 | $-257.8M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-010788 |
| FY 2022 | $-192.3M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-016486 |
| FY 2021 | $-178.3M | 2021-01-01 – 2021-12-31 | evidence 0001628280-23-016486 |
| FY 2020 | $-121.0M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-003069 |
| FY 2019 | $-95.2M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002582 |
| FY 2018 | $-68.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005808 |
| FY 2017 | $-54.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004163 |
| FY 2016 | $-71.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002900 |
| FY 2015 | $-40.7M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-012882 |
| FY 2014 | $-26.4M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000950 |
| FY 2013 | $-26.6M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-065170 |
| FY 2012 | $-22.3M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-076887 |
| FY 2011 | $-35.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-073470 |
| FY 2010 | $-24.9M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-073470 |
| FY 2009 | $-18.6M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-073470 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SANGAMO THERAPEUTICS, INC. — all facts · Revenue · Operating Income